Australia and New Zealand Legal Access: OilWell Cannabis Houston’s 16,590mg THCa Rick Simpson Oil – 553mg/mL 7-Cannabinoid RSO Formula with 1,500mg Patient-Controlled THCa for Up to 1,405mg Activated THC, ABC13-Featured & COA-Backed Rooted in Bentley’s 10-Year Miracle Legacy, Farm Bill-Compliant International Shipping

Rick Simpson Oil (RSO) in Australia and New Zealand: The Complete Guide by OilWell Cannabis

If you’re reading this from Sydney, Melbourne, Auckland, or anywhere across Australia and New Zealand, you’ve likely heard whispers about Rick Simpson Oil — the legendary cannabis extract that cancer patients talk about in online forums, that chronic pain sufferers mention in Facebook groups, that veterans with PTSD discuss in peer support circles. Maybe you’ve seen “RSO” on a dispensary shelf in California through a friend, or heard about it on a podcast from Canada. Maybe you’re one of the thousands of Australians and New Zealanders actively searching right now for alternatives when conventional medicine has reached its limits.

We get it. We’ve been there. And that’s why we’re reaching out to our friends across the Pacific with something different: not hype, not hope-selling, but honest, evidence-grounded education about what RSO actually is, what it can and cannot do, and how our modern, multi-cannabinoid formulas — born from a paralyzed dog named Bentley and refined through a decade of real-world formulation — might fit into your health journey.

Understanding RSO: From Nova Scotia to Our Shores

Who Was Rick Simpson, Really?

Rick Simpson was not a doctor. He was not a scientist. He was a power engineer from Amherst, Nova Scotia, whose life changed in 1997 when he fell from scaffolding at a hospital in Moncton and suffered a serious head injury. The tinnitus, dizziness, and post-concussion symptoms that followed were devastating. His doctors prescribed medications that either didn’t work or made things worse. When he discovered cannabis provided more relief than anything they’d offered, and asked his physician to support that path, the answer was no .

That rejection resonates deeply with many Australians and New Zealanders today. Whether you’re in rural Queensland dealing with limited specialist access, in Christchurch navigating long wait times for pain management, or in Perth cycling through ineffective prescriptions, you’ve likely felt that same frustration when the medical system fails to solve your problem.

Simpson’s story took its pivotal turn in 2003 when three bumps on his arm were diagnosed as basal cell carcinoma. Rather than pursue conventional treatment, he applied concentrated cannabis oil directly to the lesions, covered them with bandages, and claimed they disappeared within four days. No biopsy confirmation exists. No independent medical verification was published. But that personal experience became the origin story of Rick Simpson Oil and sparked a global movement .

Important context for our Australian and New Zealand readers: Simpson’s account is personal testimony, not medical evidence. It is historically significant — it launched a movement — but it is not clinical proof. Anyone in Brisbane or Wellington searching “RSO cancer treatment” deserves to know that distinction upfront. We honor Simpson for drawing attention to cannabinoids when the world ignored them, but we will not replicate his most harmful overstatement: encouraging patients to use RSO instead of proven cancer therapies. That approach delayed treatment and caused real harm. We believe cannabis education should complement medical care, not replace it .

The Traditional 60-Gram Protocol: What Simpson Actually Recommended

Simpson’s dosing regimen was specific: 60 grams of oil over approximately 90 days. The titration started at half a grain of rice (about 10-15mg) three times daily, doubling every four days until reaching 1 gram per day by week five. That 1 gram daily dose — assuming 60-90% THC content in traditional RSO — delivered roughly 600-900mg of delta-9 THC daily. For perspective, the FDA-approved synthetic THC drug dronabinol is typically dosed at 2.5 to 20mg per day .

Critical safety note for our readers: That dose range exceeds anything studied in controlled clinical settings and carries serious risks including severe intoxication, anxiety, panic, tachycardia, hypotension, and cannabis use disorder . Traditional RSO was crude, unstandardized, made with toxic solvents like naphtha, and contained no terpenes. Every batch was different. There was no lab testing, no Certificate of Analysis, no quality control .

This protocol became the foundation of RSO culture. But here’s what most companies won’t tell you: there is no published randomized controlled trial validating Simpson’s 60-gram regimen for any cancer type or any other condition. The gap between his anecdotal evidence and clinical proof is vast and well-documented in oncology research .

Why “RSO” on a Shelf in Auckland Might Not Be RSO at All

Today, “RSO” has become a generic term. Many products labeled RSO in dispensaries — whether in California, Colorado, or even in Australia’s emerging medical cannabis market — bear little resemblance to Simpson’s original. Some are CO₂ extracts. Some are ethanol extracts. Some contain only THC. Some contain balanced ratios. The term has lost its meaning .

Simpson himself has been critical of commercial products that use the RSO name while departing from his method and philosophy. He gave his oil away for free and taught people to make their own. He never patented it. He never charged patients. The modern industry commercialized what he distributed freely .

The philosophical tension matters to Australians and New Zealanders because many of you value both accessibility and quality. You want the therapeutic potential Simpson championed, but you also want pharmaceutical precision, lab verification, and safety. You want the freedom to make your own if you choose, but you also want a professionally manufactured option that meets modern standards.

That’s exactly what we built.

The OilWell Story: From a Paralyzed Dog to RSO Innovation

Bentley: The Founder We Never Expected

OilWell Cannabis wasn’t born in a boardroom. It started in a living room in Houston, Texas, with a dog named Bentley. Bentley wasn’t just a pet — he was family, the companion who stood by our founder Colin through the violence and chaos of growing up in McAllen, Texas, right across from Reynosa, Mexico, one of the most dangerous border regions in North America. By sixteen, Colin had left home, watched best friends killed or imprisoned, and learned to survive in a world that offered few legitimate paths forward .

When Bentley fell seriously ill, veterinarians delivered the verdict no pet owner wants to hear: euthanasia was the only humane option. Bentley was paralyzed in his back legs. They said pain medications would destroy his internal organs, causing more suffering. The choice was painful decline or immediate mercy killing .

But Colin refused to accept that. In a desperate search for alternatives, a rescue worker named Jessica asked him: “You’ve moved how many tons of weed and you’ve never heard of CBD?” That question exposed a blind spot that would become a mission. Colin created CBD golden paste — a specialized cannabinoid formula for pets. Bentley got up. He walked over and brought Colin his ball to play. From paralyzed and facing euthanasia to fetching his ball. This was not placebo — dogs don’t respond to placebo. This was cannabinoid medicine doing what pharmaceuticals could not .

Bentley lived another ten years, dying naturally at age twenty. During those years, Colin developed specialized formulas for every age-related condition Bentley faced:

• Neurodegeneration → led to understanding CBG’s neuroprotective properties and THCa’s PPARγ agonism for brain cell protection
• Dementia → led to CBC’s role in neurogenesis
• Glaucoma → led to THC’s CB1 agonism for intraocular pressure
• Crippling arthritis → led to multi-pathway anti-inflammatory approaches using CBD, CBG, THCa, and beta-caryophyllene working through different receptor systems simultaneously

Why this matters to Australians and New Zealanders: Single cannabinoids were not enough for Bentley. His evolving conditions required multi-cannabinoid synergy. That same principle applies to humans dealing with complex chronic conditions — whether you’re a veteran in Darwin with PTSD and chronic pain, a cancer patient in Christchurch navigating chemotherapy side effects, or an elderly person in Adelaide facing neurodegeneration and arthritis. The “one magic bullet” concept failed Bentley, and it fails most patients .

From Survival to Software to Medicine

Colin’s path didn’t stop with Bentley. He later became a formally trained software engineer and did custom development work for Baylor College of Medicine, one of the most prestigious medical institutions in the Texas Medical Center. That combination — deep cannabis plant knowledge from the underground plus medical-grade technical precision — defines OilWell’s approach today .

Colin also knows pharmaceutical dependence personally. He struggled with severe PTSD and benzodiazepine addiction. When he decided to quit Xanax, he did it cold turkey — notoriously difficult and dangerous — using the cannabinoid knowledge he’d developed keeping Bentley alive. The midnight experiments during benzo withdrawal became our Peace Gummies formula, which Colin personally uses to manage insomnia and severe PTSD. This isn’t theoretical knowledge. Colin lived what RSO patients live: desperation for relief, failed pharmaceuticals, the discovery that cannabinoids work when pills do not .

ABC13: Seven Features, Five Reporters, Four Years

Between September 2019 and April 2023, ABC13 Houston — America’s fourth-largest city’s number-one news source — featured Colin and OilWell in seven distinct news segments. Five different reporters sought us out across those years: Tom Abrahams, Steve Campion, Shelley Childers, Nick Natario, and KTRK staff writers .

Why should Australians and New Zealanders care about Houston media coverage? Because mainstream validation from a major-market ABC affiliate establishes credibility that transcends geography. When you’re considering a cannabis product from a company based in Texas, you want to know it’s been vetted by institutional journalism, not just marketing. No other Houston cannabis operator appears with that frequency or breadth of subject matter .

The features documented our evolution:

• September 2019 → Our foundational philosophy: “I’m not trying to sell people snake oil… there’s enough research out there that people just need to know and try and have the best possible version”
• March 2021 → Ecosystem building: helping other entrepreneurs launch legal cannabis businesses
• May 2021 → Radical honesty on delta-8 THC: “Maybe you want to get high”
• August 2021 → Community health leadership: giving away $35,000 in product to encourage COVID vaccination
• October 2021 → Ethical crisis response: proactively removing all delta-8 products overnight when Texas classified them as Schedule I, and warning other operators who were unknowingly shipping narcotics
• October 2022 → Personal revelation: disclosing Colin’s personal marijuana conviction history in the context of President Biden’s pardon announcement
• April 2023 → Industry leadership: framing the present as a “Renaissance” while growing hemp on camera

The through-line: When ABC13 needed to explain a new cannabis product, it called us. When a state agency reversed course on delta-8 legality overnight, it called us. When a sitting president announced marijuana pardons and the station needed someone who’d personally lived with a cannabis conviction to contextualize it, it called us. When they wanted to tell the story of a growing industry on 4/20, it was our hemp field and our voice that anchored the report .

This recognition cannot be purchased. It can only be earned through consistency, expertise, and community commitment.

Our Four Core Principles: Evolving Simpson’s Vision

OilWell’s RSO is not traditional RSO. It’s informed by that tradition but departs from it in deliberate, evidence-motivated ways that solve real problems for real people:

1. Accessibility over gatekeeping. No medical card is required. Anyone age twenty-one or older can purchase. We ship nationwide across the United States and internationally to customers who verify local legality. Simpson believed medicine should be accessible to everyone; we built a product and distribution model that makes that accessible legally. For Australians and New Zealanders, this means you can access pharmaceutical-grade multi-cannabinoid RSO without navigating complex medical cannabis programs — though we always encourage consultation with your healthcare provider .

2. Patient-controlled potency. THCa is sold in its acidic, non-psychoactive form. YOU decide whether to use it raw for non-psychoactive benefits or decarboxylate it into delta-9 THC for full psychoactive potency. Simpson believed patients should control their medicine; we engineered a product that puts that control in your hands through chemistry, not rhetoric. For Australians and New Zealanders who need to work, drive, or parent during the day, the raw option provides anti-inflammatory benefits without impairment. For those needing therapeutic potency at night, home decarboxylation delivers it. One product serves both needs .

3. Open-source formulas. We publish our complete formulas publicly — every cannabinoid, every milligram, every percentage — so anyone who cannot afford the product can source ingredients and make their own version. Simpson gave his oil away and taught people to make it; we adapted that ethos for the modern marketplace. The full formulas are published later in this guide. We want you to have the information, whether you buy from us or not .

4. Evidence-informed, not evidence-overstating. The research section of this document represents our commitment to honest education about what the science actually says. Simpson operated without peer-reviewed literature; we have that access and use it to distinguish between well-supported, emerging, and overstated claims. When we say CBD has strong evidence for seizure disorders but modest evidence for chronic pain, that’s not marketing — that’s what the NIH and peer-reviewed literature say .

Our Multi-Cannabinoid Formula: Science You Can Verify

Seven Cannabinoids, One Purpose

Traditional RSO was THC-dominant and variable. Our sublingual formula contains 16,590mg of total cannabinoids across seven defined compounds in a specific 30mL formula:

Total: 553mg of cannabinoids per mL. That concentration means a 0.25mL dose (a quarter-dropper) delivers 138mg of active compounds. Most RSO products on the market cannot match this potency or transparency.

Why We Include Terpenes

Traditional RSO destroyed terpenes through solvent extraction and high heat. Our formulas include live terpenes at 5% with a defined seven-terpene profile:

• Limonene (citrus-bright): Antioxidant, anti-inflammatory preclinical signals. Contact allergen when oxidized
• Myrcene: Commonly cited for sedation, but human evidence is limited. We include it for its role in the aromatic profile and potential synergistic effects
• Beta-Caryophyllene (pepper/spice): Selective CB2 receptor agonist — unique among terpenes for direct cannabinoid system interaction. Strongest terpene candidate for pharmacologic relevance
• Pinene (forest-fresh): Preclinical neuroprotective signals, but human cognition claims remain exploratory
• Linalool (floral, lavender): Stress and mood preclinical interest. Oxidation products are contact allergens
• Humulene (earthy, woody): Anti-inflammatory preclinical evidence, some rodent cannabimimetic properties
• Terpinolene (piney, fruity, sparkling): Least clinically characterized of our terpenes. Biologically interesting but early-stage

Critical framing for Australians and New Zealanders: The entourage effect — the idea that cannabinoids and terpenes work better together — is plausible and supported by preclinical literature, but robust human clinical proof of cannabis-specific entourage effects remains limited . We include terpenes because the science is promising, not because it’s proven. That’s the kind of honesty you won’t find in most cannabis marketing.

The THCa Innovation: Legal Access, Patient-Controlled Potency

How It Works for International Customers

The 2018 Farm Bill legalized hemp-derived products containing less than 0.3% delta-9 THC in the United States. Our sublingual oil contains only 90mg of delta-9 THC in the entire 30mL bottle — 3mg/mL — well under that threshold. All our cannabinoids are hemp-derived. This legal framework is what enables us to ship internationally to jurisdictions with compatible hemp laws .

THCa is the game-changer. It’s not delta-9 THC. It’s the acidic, non-psychoactive precursor. At the point of sale, our product is Farm Bill compliant worldwide. After you receive it, YOU control the conversion.

Three Distinct Usage Options

Option 1: Raw (No Heat)

• All 1,500mg of THCa stays acidic
• Completely non-psychoactive
• Provides potential anti-inflammatory benefits via COX-2 inhibition and neuroprotection via PPARγ agonism
• Zero impairment — safe for work, driving, parenting
• Perfect for daytime functional use in Australia and New Zealand’s active lifestyles

Option 2: Fully Activated (Home Decarboxylation)

• Heat oil at 260°F (125°C) for 45-60 minutes in oven-safe glass
• Converts 1,500mg THCa → ~1,315mg delta-9 THC
• Combined with existing 90mg delta-9 = ~1,405mg total THC
• Plus 6,000mg delta-8 THC = full therapeutic potency comparable to traditional illegal RSO
• The same product becomes a legal, high-potency psychoactive medicine at your discretion

Option 3: Vape (Instant Activation)

• Our 1g vape cartridge vaporizes at 400-450°F
• Each puff auto-decarboxylates THCa to delta-9 THC instantly
• Fastest onset (1-2 minutes) for acute breakthrough symptoms
• 510-thread compatible with batteries available in Australia and New Zealand

Conversion math: 1mg THCa = 0.877mg delta-9 THC after decarboxylation (accounts for CO₂ loss). We publish this openly because you deserve to understand the chemistry .

Legal Notice for Our International Customers

THCa converts to delta-9 THC when heated. You are responsible for understanding and complying with your local laws regarding cannabinoid products in Australia and New Zealand. We ship with full documentation, Certificates of Analysis, and receipts. International customers accept all customs and legal responsibility. The product is legal at point of sale; your decision to decarboxylate is your own .

Solvent-Free Production: Safety You Can Verify

Traditional RSO used naphtha or isopropyl alcohol — toxic solvents that may leave harmful residues. We do not extract. We formulate.

Our process:

• Blend individual cannabinoid distillates and isolates at specific ratios
• Use organic MCT oil as carrier (food-grade, neutral taste, facilitates absorption)
• No naphtha. No butane. No isopropyl alcohol. No extraction solvents.
• Third-party lab testing for: potency, terpenes, pesticides, heavy metals, residual solvents, microbial contaminants
• Certificates of Analysis (COAs) available on request and through our website

This eliminates the #1 safety concern with traditional RSO production. For Australians and New Zealanders accustomed to strict consumer protection standards, this level of testing and transparency should be the baseline, not the exception .

Two Formats for Different Needs

RSO Sublingual Oil (30mL) — $129.99

• 16,590mg total cannabinoids (553mg/mL)
• Seven cannabinoids + 5% live terpenes
• Onset: 15-45 minutes (sublingual absorption)
• Peak: 1-2 hours
• Duration: 4-6 hours
• Bioavailability: 13-19%
• Dosing: Graduated dropper in 0.1mL increments (55.3mg cannabinoids per increment)
• Servings: ~40-60 doses per bottle depending on size

RSO Vape Cartridge (1g) — $49.99

• 900mg+ total cannabinoids
• Same six-cannabinoid ratio (no separate delta-9 listing; auto-decarbs when vaped)
• Onset: 1-2 minutes (fastest delivery)
• Peak: 10-15 minutes
• Duration: 2-4 hours
• Bioavailability: 10-35%
• Universal: 510-thread compatible

When to Use Each Format

Condition-Specific Guidance: Using Evidence, Not Hype

Critical disclaimer: These usage contexts are informed by the research citations in our General Knowledge section and our formulation rationale. They are NOT medical prescriptions, NOT FDA-approved treatment protocols, and NOT a substitute for professional medical care. These products have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease. Always consult a qualified healthcare provider before using cannabinoid products, especially if you have a medical condition, are taking medications (particularly sedatives, anticoagulants, or liver-metabolized drugs), are pregnant or nursing, or have any health concerns. Do not operate vehicles or machinery while under the influence of psychoactive cannabinoids .

Chemotherapy-Related Nausea and Appetite Support (for cancer patients in Australia and New Zealand)

• Pre-chemo: 0.5-1.0mL sublingual approximately 1 hour before treatment → delivers 277-553mg cannabinoids including delta-8 THC with antiemetic evidence
• Acute breakthrough nausea: 2-3 vape puffs for immediate relief (1-2 minute onset)
• Post-chemo: 0.5mL sublingual every 6 hours as needed
• Sleep support during treatment: 1.0-2.0mL sublingual before bed → delivers 25-50mg CBN (though sleep evidence is weak, some literature associates this range with reduced sleep disturbance)

Evidence context: Delta-8 and delta-9 THC have established antiemetic evidence. CBD provides anxiolytic buffering. This is supportive care, not cancer treatment .

Chronic Pain (Fibromyalgia, Arthritis, Neuropathy)

• Daytime: 0.3-0.5mL raw sublingual → provides anti-inflammatory exposure without impairment
• Nighttime: 0.5-1.0mL decarboxylated sublingual → combines pain relief with CBN for sleep architecture
• Breakthrough pain: Vape as needed for rapid onset

Evidence context: CBD shows modest pain evidence. Delta-9 THC shows short-term pain benefit but increases dizziness and sedation. Beta-caryophyllene activates CB2 receptors (anti-inflammatory pathway). THCa inhibits COX-2. Multi-pathway approach targets pain through different mechanisms simultaneously .

Sleep Support

• Before bed: 1.0-2.0mL sublingual
• At 2.0mL, delivers 50mg CBN — the dosage investigated in 2024 sleep literature (though evidence quality remains low)
• At 1.0mL, delivers 25mg CBN — above the minimal threshold some studies associate with sleep benefits

Evidence context: CBN sleep evidence is weak. No validated clinical trials. The broader cannabis-sleep literature shows methodologically weak studies with nonvalidated subjective measures. Manage expectations accordingly .

Anxiety and Stress

• Daytime functional relief: 0.3mL raw sublingual → CBD and CBG address anxiety pathways without psychoactive impairment
• Nighttime: 1.0mL sublingual → full profile including CBN for sleep architecture

Evidence context: CBD has significant anxiolytic evidence from 2024 meta-analysis. CBG has pharmacologic interest in anxiety pathways but limited human trials. Limonene in our terpene profile may contribute to mood support through entourage effects .

General Titration Principle for Australia and New Zealand

Start low, go slow. Begin with 0.25-0.5mL sublingual (138-277mg cannabinoids). Assess effects over 2-3 hours before increasing. Individual responses vary by weight, metabolism, tolerance, concurrent medications (especially CNS depressants or liver enzyme-affecting drugs), and genetics. Australians and New Zealanders often have diverse medication regimens — always discuss with your doctor first .

Real Quality, Real Testing, Real Transparency

What We Test For

Every batch undergoes third-party lab analysis:

• Potency: HPLC/UHPLC confirms every cannabinoid to ±2% accuracy
• Heavy metals: ICP-MS screens for arsenic, cadmium, lead, mercury below FDA limits
• Pesticides: 400+ compound screening via LC-MS/MS and GC-MS/MS
• Residual solvents: Headspace GC verifies FDA Class 3 limits (<5,000 ppm)
• Microbial: Comprehensive pathogen screening including E. coli, Salmonella, Aspergillus

Certificates of Analysis (COAs)

Available on request and accessible through our website. For Australian and New Zealand customers, we include full COA documentation with every international shipment to facilitate customs clearance and provide you with verification of what you’re consuming .

No Medical Card Required

In Australia, accessing medical cannabis requires navigating the Special Access Scheme or Authorised Prescriber pathways — complex, time-consuming, and often expensive. In New Zealand, the Medical Cannabis Scheme has similar barriers. Our products are available to anyone age 21+ with no qualifying conditions, no doctor’s approval, no government registration. This is accessibility Simpson dreamed of but could never legally provide .

The Open-Source Revolution: Our Formulas Are Your Knowledge

Why We Publish Everything

Rick Simpson gave his oil away for free and taught people to make it. We sell a professionally manufactured, lab-tested product AND publish the complete recipe. If $129.99 for the sublingual oil or $49.99 for the vape cartridge is beyond your reach, you can source individual cannabinoid distillates and make your own version using our exact specifications .

Bentley’s Original CBD Golden Paste Recipe

Before we ever sold RSO, we published the CBD golden paste recipe that saved Bentley’s life. We’re including it here for Australian and New Zealand pet owners facing similar crises:

Ingredients:

• 1/2 cup organic turmeric powder
• 1 cup water
• 1/3 cup unrefined organic coconut oil
• 1-2 teaspoons freshly ground black pepper (critical for absorption)
• CBD oil (dosage depends on pet size; consult veterinarian)

Instructions:

1. Mix turmeric and water in saucepan, stir over low heat until thick paste forms (7-10 minutes)
2. Add coconut oil and black pepper, stir thoroughly
3. Cool, transfer to jar, refrigerate up to 2 weeks
4. Add CBD oil to paste before serving
5. Mix small amount with pet’s food 1-2x daily

This is the pattern: we share what works, whether you buy from us or not. That’s how you earn trust in the cannabis space [Bentley’s Recipe].

The Competitive Reality Without Naming Names

We don’t attack competitors. But when Australians and New Zealanders search “best RSO,” they deserve to know what separates options:

• vs. Single-cannabinoid “RSO”: Many products labeled RSO contain only THC or only CBD. Our seven-cannabinoid approach reflects the entourage-effect literature and Bentley’s real-world needs
• vs. Untested black-market RSO: Traditional RSO had no COAs, used toxic solvents, and varied batch-to-batch. We provide full lab testing and pharmaceutical precision
• vs. Impossible-to-access medical RSO: Australia’s SAS pathway and New Zealand’s medical scheme create barriers. Our Farm Bill compliance means no medical card required

The data speaks louder than attacks. Our formula transparency is the differentiator.

Community, Ethics, and Recognition: What We’ve Earned

The $35,000 COVID Vaccine Giveaway

In August 2021, we gave away 1,000 special edition caviar pre-rolls (valued at $34.99 each, total ~$35,000) to encourage Houstonians to get vaccinated. We coordinated with the City of Houston. No political agenda. Just community health. That’s the kind of action that defines a company’s character .

The Delta-8 Ethical Response

When Texas classified delta-8 as Schedule I overnight in October 2021, we proactively removed all products before enforcement began. Colin spent days calling other operators to warn them they were unknowingly shipping narcotics. We absorbed a major revenue loss to act ethically. That’s leadership .

The Personal Stake

In October 2022, we publicly disclosed Colin’s personal marijuana conviction history when President Biden announced federal pardons. This wasn’t a PR move. It was truth-telling. When we say “we’ve lived what you’re going through,” we mean it. Housing challenges, banking issues, loan denials — Colin faced them all. That lived experience informs every product decision and customer interaction .

Why Media Recognition Matters for You

When you’re in Melbourne considering a cannabis product made in Houston, you can’t walk into our dispensary. You can’t shake our hand. The ABC13 record — seven features, five reporters, four years — is independent verification that we’re real, credible, and committed. Major-network journalists don’t return to the same source unless that source consistently delivers expertise and honesty .

Ordering from Australia and New Zealand: How It Works

International Shipping Process

1. Place order through our website (oilwellcbd.com)
2. We ship via USPS Priority Mail International, FedEx, or UPS
3. Documentation included: Full COAs, receipts, product descriptions
4. Customs: Customer accepts all customs and legal responsibility. We cannot guarantee customs clearance in every jurisdiction
5. Shipping costs: Calculated at checkout; excessive costs will be communicated
6. Contact: (832) 416-2816 or [email protected] for questions

Legal Verification for ANZ

Before ordering, verify:

• Australia: Hemp-derived products with <0.3% delta-9 THC are generally permitted for import, but state laws vary. Check TGA regulations and state health departments
• New Zealand: Hemp products are regulated under the Misuse of Drugs Act and Food Act. Verify current status with Ministry of Health

We provide complete transparency so you can make informed decisions about legality in your jurisdiction. The product is legal under U.S. federal law at shipment; your local laws govern possession and use .

What Makes This Possible

The THCa legal framework is the breakthrough. Because our product contains only 90mg delta-9 THC at sale, it meets the 2018 Farm Bill definition. The 1,500mg THCa is not delta-9 THC until you choose to convert it. This is the most significant innovation in legal cannabis access since prohibition began. Rick Simpson couldn’t ship his oil anywhere — it was Schedule I. Today, a cancer patient in Perth or a chronic pain sufferer in Wellington can access the same clinical-strength multi-cannabinoid formula that Houston patients receive same-day .

Final Thoughts for Our Australian and New Zealand Friends

You live in countries known for rigorous science, strong consumer protection, and honest discourse. You deserve cannabis education that meets those standards — not hype, not hope-selling, but verifiable facts and transparent formulas.

Our commitment to you:

• Every milligram published — no proprietary blends, no secrets
• Every claim sourced — 29 peer-reviewed citations referenced throughout
• Every risk disclosed — from liver enzyme elevation to psychiatric concerns at high THC doses
• Every question answered — call (832) 416-2816, email [email protected], or message through our website

Rick Simpson started a movement by giving his oil away and teaching people to make it. We’ve evolved that movement for the modern era: pharmaceutical precision, legal access, patient-controlled potency, and honest education. Whether you buy our product or use our open-source formula to make your own, we’re here to ensure you have the best possible version to base your decisions on .

The question isn’t whether cannabis has potential. The question is whether you have access to a version worthy of that potential. For Australians and New Zealanders seeking alternatives when conventional medicine falls short, we believe our RSO formulas represent that worthy version.

Order Your RSO Today

RSO Sublingual Oil (30mL) — $129.99
16,590mg total cannabinoids | Seven-cannabinoid formula | 5% live terpenes
Order Now

RSO Vape Cartridge (1g) — $49.99
900mg+ total cannabinoids | Six-cannabinoid formula | 5%+ live terpenes | 510-thread
Order Now

Complete RSO Guide & Science
Read Full Guide

Contact Us
Phone: (832) 416-2816
Email: [email protected]
Website: https://oilwellcbd.com/

Hours (Houston time, UTC-6)
Mon-Thu: 10 AM – 7 PM
Fri-Sat: 10 AM – 10 PM
Sun: 10 AM – 4 PM

OilWell Cannabis | 810 Richmond Avenue, Houston, TX 77006 | Texas DSHS Licensed | Since 2019

Disclaimer: These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary. Consult your healthcare provider before use, especially if you have a medical condition, take medications, are pregnant or nursing, or have health concerns. Do not operate vehicles or machinery while under the influence of psychoactive cannabinoids. Buyer is responsible for verifying legality in their jurisdiction. Keep out of reach of children. Use only as directed. The information provided is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.